Xylazine Use in Veterinary Sedation
Xylazine injection is primarily used in veterinary medicine as a sedative, analgesic, and muscle relaxant for horses and Cervidae (deer species and elk) at specific dosages based on animal type and weight, with intramuscular administration being the most common route. 1
Dosage and Administration
Horses
- Intramuscular (IM): 1.0 mL/100 lbs body weight (1.0 mg/lb)
- Intravenous (IV): 0.5 mL/100 lbs body weight (0.5 mg/lb) 1
Cervidae (Deer and Elk)
- Intramuscular only (hand syringe or dart):
- Fallow Deer: 2.0-4.0 mL/100 lbs (2.0-4.0 mg/lb)
- Mule Deer: 1.0-2.0 mL/100 lbs (1.0-2.0 mg/lb)
- Sika Deer: 1.0-2.0 mL/100 lbs (1.0-2.0 mg/lb)
- White-Tailed Deer: 1.0-2.0 mL/100 lbs (1.0-2.0 mg/lb)
- Elk: 0.25-0.5 mL/100 lbs (0.25-0.5 mg/lb) 1
Clinical Effects and Duration
Following injection, the animal should rest quietly until the full effect develops:
- Sedation: Usually maintained for 1-2 hours
- Analgesia: Lasts for 15-30 minutes 1
Veterinary Clinical Applications
Horses
Diagnostic procedures:
- Oral and ophthalmic examinations
- Abdominal and rectal palpation
- Vaginal examination
- Bladder catheterization
- Radiographic examinations
Orthopedic procedures:
- Application of casting materials and splints
Dental procedures
Minor surgical procedures:
- Debridement
- Removal of cutaneous neoplasms
- Suturing lacerations
Behavioral management:
- Calming and facilitating handling of fractious animals
Therapeutic use:
- Sedation and pain relief following injury or surgery
Major surgical procedures:
- As a preanesthetic to general anesthesia
- In conjunction with local anesthetics 1
Cervidae (Deer and Elk)
Behavioral management:
- Calming and facilitating handling of fractious animals
Diagnostic procedures
Minor surgical procedures
Therapeutic use:
- Sedation and pain relief following injury or surgery
As a preanesthetic to local anesthesia 1
Pharmacological Properties and Mechanism
Xylazine stimulates presynaptic α-2 adrenergic receptors in the brain, triggering a negative feedback signal that reduces central catecholamine release. This results in:
- Decreased sympathetic nervous system outflow
- Sedation
- Relative and generally limited hypotension and bradycardia 2
In large doses, xylazine initially causes peripheral vasoconstriction and occasionally transient hypertension due to its effects on vascular α-adrenergic receptors 2. In mice and rats, xylazine is often combined with ketamine for anesthesia, with specific dosages:
- Mice: Ketamine (100 mg/kg), xylazine (20 mg/kg), and atropine (0.6 mg/kg)
- Rats: Ketamine (50-75 mg/kg) and xylazine (1-5 mg/kg) 2
Important Considerations and Precautions
Anesthetic combinations:
Potential adverse effects:
Human misuse concerns:
- Not approved for human use
- Has emerged as an adulterant in recreational drugs, particularly opioids 3, 4
- Human intoxication can cause central nervous system depression, respiratory depression, bradycardia, hypotension, and even death 4
- No specific antidote for humans; naloxone is ineffective for xylazine toxicity 5
Monitoring and Recovery
- Animals should be allowed to rest quietly until the full effect has been reached
- Post-anesthetic or emergence excitement has not been observed in animals preanesthetized with xylazine 1
- Monitor for bradycardia and hypotension, especially when combined with other anesthetics
By understanding the proper dosing, administration, and clinical applications of xylazine in veterinary medicine, practitioners can effectively utilize this sedative while minimizing potential risks.